ATE114968T1 - Verfahren zur herstellung von bromocriptin enthaltenden arzneimittelzubereitungen mit hoher stabilität und in beziehung zueinander stehende produkte. - Google Patents

Verfahren zur herstellung von bromocriptin enthaltenden arzneimittelzubereitungen mit hoher stabilität und in beziehung zueinander stehende produkte.

Info

Publication number
ATE114968T1
ATE114968T1 AT90106403T AT90106403T ATE114968T1 AT E114968 T1 ATE114968 T1 AT E114968T1 AT 90106403 T AT90106403 T AT 90106403T AT 90106403 T AT90106403 T AT 90106403T AT E114968 T1 ATE114968 T1 AT E114968T1
Authority
AT
Austria
Prior art keywords
products
bromocriptin
manufacture
high stability
containing medicinal
Prior art date
Application number
AT90106403T
Other languages
English (en)
Inventor
Luigi Moro
Achille Fiori
Alberto Natali
Original Assignee
Poli Ind Chimica Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Poli Ind Chimica Spa filed Critical Poli Ind Chimica Spa
Application granted granted Critical
Publication of ATE114968T1 publication Critical patent/ATE114968T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT90106403T 1989-04-07 1990-04-04 Verfahren zur herstellung von bromocriptin enthaltenden arzneimittelzubereitungen mit hoher stabilität und in beziehung zueinander stehende produkte. ATE114968T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT8920063A IT1235053B (it) 1989-04-07 1989-04-07 Metodi per la preparazione di composizioni farmaceutiche a base di bromocriptina dotate di elevata stabilita' e prodotti derivanti.

Publications (1)

Publication Number Publication Date
ATE114968T1 true ATE114968T1 (de) 1994-12-15

Family

ID=11163518

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90106403T ATE114968T1 (de) 1989-04-07 1990-04-04 Verfahren zur herstellung von bromocriptin enthaltenden arzneimittelzubereitungen mit hoher stabilität und in beziehung zueinander stehende produkte.

Country Status (9)

Country Link
US (1) US5066495A (de)
EP (1) EP0391374B1 (de)
AT (1) ATE114968T1 (de)
DD (1) DD293961B5 (de)
DE (2) DE69014691T2 (de)
DK (1) DK0391374T3 (de)
ES (1) ES2029776T3 (de)
GR (1) GR900300172T1 (de)
IT (1) IT1235053B (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2030174C (en) * 1990-01-10 1996-12-24 Anthony H. Cincotta Process for the long term reduction of body fat stores, insulin resistance, hyperinsulinemia and hypoglycemia in vertebrates
US5292520A (en) * 1990-09-13 1994-03-08 Akzo N.V. Stabilized solid pharmaceutical composition containing acid addition salts of a basic drug and an alkaline stabilizer
US5225204A (en) * 1991-11-05 1993-07-06 Chen Jivn Ren Stable dosage of levothyroxine sodium and process of production
IL112106A0 (en) * 1993-12-22 1995-03-15 Ergo Science Inc Accelerated release composition containing bromocriptine
SI9700186B (sl) 1997-07-14 2006-10-31 Lek, Tovarna Farmacevtskih In Kemicnih Izdelkov, D.D. Nova farmacevtska oblika z nadzorovanim sproscanjem zdravilnih ucinkovin
US6129931A (en) * 1998-09-03 2000-10-10 Isp Investments Inc. Controlled-release, drug-delivery tableted composition including a complex between poly(maleic diacid-alkyl vinyl ether) and polyvinylpyrrolidone
JP2005513080A (ja) * 2001-12-20 2005-05-12 フェムファーマ， インコーポレイテッド 薬物の膣送達
US8821915B2 (en) 2002-08-09 2014-09-02 Veroscience, Llc Therapeutic process for the treatment of the metabolic syndrome and associated metabolic disorders
US9173836B2 (en) 2003-01-02 2015-11-03 FemmeParma Holding Company, Inc. Pharmaceutical preparations for treatments of diseases and disorders of the breast
MXPA05007266A (es) * 2003-01-02 2006-01-17 Femmepharma Holding Co Inc Preparaciones farmaceuticas para tratamientos de enfermedades y trastornos del seno.
AU2007216882B2 (en) * 2003-01-02 2010-03-11 Femmepharma Holding Company, Inc. Pharmaceutical preparations for treatment of diseases and disorders of the breast
WO2008083158A2 (en) * 2006-12-26 2008-07-10 Femmepharma Holding Company, Inc. Topical administration of danazol
GB0715628D0 (en) * 2007-08-10 2007-09-19 Generics Uk Ltd Solid valsartan composition
US9352025B2 (en) 2009-06-05 2016-05-31 Veroscience Llc Combination of dopamine agonists plus first phase insulin secretagogues for the treatment of metabolic disorders
US20110003000A1 (en) * 2009-07-06 2011-01-06 Femmepharma Holding Company, Inc. Transvaginal Delivery of Drugs
US8431155B1 (en) 2012-04-30 2013-04-30 Veroscience Llc Bromocriptine formulations
CN105640901A (zh) * 2014-11-10 2016-06-08 匈牙利吉瑞大药厂 一种利用新型生产工艺制备甲磺酸溴隐亭片的方法及其应用
EP3925610A1 (de) 2016-04-20 2021-12-22 VeroScience LLC Zusammensetzung und verfahren zur behandlung von stoffwechselstörungen
EP3697418A4 (de) 2017-10-18 2021-07-14 VeroScience LLC Verbesserte bromocriptin-formulierungen

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL273962A (de) * 1962-01-25
US3836618A (en) * 1971-12-23 1974-09-17 American Home Prod Process for the uniform distribution of a drug on a granulated base
NL7314066A (de) * 1972-10-18 1974-04-22
DE3045135A1 (de) * 1980-11-29 1982-06-09 Sandoz-Patent-GmbH, 7850 Lörrach Pharmazeutische kompositionen enthaltende bioabbaubare polymere
US4479911A (en) * 1982-01-28 1984-10-30 Sandoz, Inc. Process for preparation of microspheres and modification of release rate of core material
NO832446L (no) * 1982-07-06 1984-01-30 Sterwin Ag, Fremgangsmaate ved fremstilling av tabletter.
US4742054A (en) * 1982-11-23 1988-05-03 Naftchi Nosrat E Treatment of mammals suffering from damage to the central nervous system
GB2154874B (en) * 1984-02-29 1987-11-04 Sandoz Ltd Bromoscriptine compositions

Also Published As

Publication number Publication date
ES2029776T1 (es) 1992-10-01
ES2029776T3 (es) 1995-02-01
DD293961B5 (de) 1994-11-10
DK0391374T3 (da) 1995-04-24
DE69014691T2 (de) 1995-04-20
GR900300172T1 (en) 1991-09-27
EP0391374B1 (de) 1994-12-07
EP0391374A2 (de) 1990-10-10
IT1235053B (it) 1992-06-17
DE391374T1 (de) 1991-02-28
EP0391374A3 (de) 1992-07-01
US5066495A (en) 1991-11-19
IT8920063A0 (it) 1989-04-07
DE69014691D1 (de) 1995-01-19

Similar Documents

Publication Publication Date Title
ATE114968T1 (de) Verfahren zur herstellung von bromocriptin enthaltenden arzneimittelzubereitungen mit hoher stabilität und in beziehung zueinander stehende produkte.
DE69331378D1 (de) Verfahren zur Herstellung von schnelllöslicher Tabletten und schnelllöslichen Tablette beinhaltend Xylitol
ES8603753A1 (es) Procedimiento de fabricacion de comprimidos efervescentes
ATE74513T1 (de) Stabilisierte arzneistoffe, verfahren zu ihrer herstellung sowie stabile arzneizubereitungen.
HU903846D0 (en) Process for producing imidazolyl-alkenic acids and pharmaceutical preparatives containing these compounds as active substance
FI905956A (fi) Foerfarande foer producering av ett biologiskt aktivt protein.
ATE134507T1 (de) Mikroverkapseltes sonnenschutzmittel, das verfahren zur herstellung, kosmetische und pharmazeutische zubereitungen mit mikrokapseln und verwendung derselben
HUT40332A (en) Process for preparing pharmaceutical compositions containing phospholipides
ATE330943T1 (de) Herstellungsverfahren von huperzine a und deren analogen und verbindungen nützlich dazu
DE3767998D1 (de) Clodronat-haltige arzneimittel und verfahren zur herstellung derselben.
ATE59960T1 (de) Theophyllintabletten mit verzoegerter freigabe.
SE8800080D0 (sv) Lekemedelskomposition
DK330787A (da) Stabiliseret farmaceutisk sammensaetning
ATE136465T1 (de) Verwendung von gibberellinen zur herstellung eines arzneimittels zur behandlung von prostatitis
DE3875144T2 (de) Verfahren zur herstellung magensaftstabiler und darmloeslicher kuegelchen von verdauungsenzymen und die auf diese weise erhaltenen arzneimittel.
HUT51146A (en) Process for production of healing compositions containing active substances of medicinal plants
PT88880A (pt) Processo para a preparacao de um comprimido e de uma composicao para esse fim contendo um acido ftalazinacetico
ATE51147T1 (de) Verfahren zur herstellung einer kombinierten pharmazeutischen zusammensetzung in einer granulaeren heterogenen dosisform mit erhoehter bioverfuegbarkeit.
HU907627D0 (en) Process for producing diamides of pyridine-2,4 and 2,5-dicarboxylic acid and pharmaceutical preparatives containing these compounds as active substances
RU93021179A (ru) Средство для профилактики и лечения гепатитов и гепатохолециститов
SU1630040A1 (ru) Способ гранулирования лекарственных веществ
ATE53384T1 (de) 3-mercapto-2-oxo-1-pyrrolidinessigsaeurederivate verfahren zur herstellung und pharmazeutische zusammensetzungen die sie enthalten.
FR2599032B1 (fr) Nouveaux fluorophosphates simples ou mixtes d'amino-acides, leur preparation, et leur utilisation comme medicament, notamment dans le traitement des syndromes degeneratifs de l'os

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EEIH Change in the person of patent owner
REN Ceased due to non-payment of the annual fee